BioNet receives positive EMA opinion on new pertussis vaccine
November 19, 2025Research and Development BioNet, Vaccine
BioNet has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency …
1nhaler receives £1.5m in funding to develop new cardboard inhaler
November 19, 2025Research and Development 1nhaler, asthma
1nhaler, a Scotland-based developer of drug delivery devices, has received £1.5m in seed funding for the development of its new …
Molnlycke donates risk prediction patent to SKF’s digital patent platform
November 14, 2025Business Services Digital Platforms, Mölnlycke, SKF, The Patent Bay
Mölnlycke Health Care, a medtech company specialising in wound care and surgical solutions, has donated a risk prediction patent to …
Study finds at-home brain stimulation therapies reduce depression relapse rate
November 14, 2025Research and Development Brain Stimulation Therapies, Flow Neuroscience, Transcranial Direct Current Stimulation Therapy, depression
A new study published in the Journal of Affective Disorders has found that home-based, transcranial, direct current stimulation (tDCS) therapy, …
Smurfit Westrock unveils new clinical packaging facility at Dublin Airport
November 13, 2025Medical Communications Dublin, Smurfit Westrock, clinical packaging facility
Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role at the forefront of global healthcare. …
EVerZom enters research and licensing agreement with GENFIT
November 13, 2025Research and Development EVerZom, Eviv, GENFIT, Liver Diseases, collaboration, licensing agreement
EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …
University of Birmingham scientists develop new MRI contrast agent
November 12, 2025Research and Development Diagnostics, MRI, University of Birmingham, medical imaging
Researchers at the University of Birmingham, UK, have developed a new class of magnetic resonance imaging (MRI) contrast agents that …
Custom Pharmaceuticals launches new company for drug product development
November 12, 2025Business Services Centrix Pharma Solutions, Company Launch, Custom Pharmaceuticals, collaboration, drug development, university of sussex
Customs Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO), has launched Centrix Pharma Solutions, a new company targeting faster …
Novartis receives SMC approval for early breast cancer treatment
November 11, 2025Research and Development Novartis, Scottish Medicines Consortium, breast cancer, nhs scotland
Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval for use within NHS Scotland …
Chiesi expands La Chaussée-Saint-Victor site to manufacture next-gen inhalers
November 10, 2025Manufacturing and Production Chiesi, Metered Dose Inhalers, Site Expansion, respiratory diseases
Chiesi, a biopharma group focused on treating respiratory diseases, has inaugurated an expansion of its manufacturing and industrial site in …
Richmond Pharmacology appoints Dr Edward Jackson as Medical Director
November 7, 2025CRO, Richmond Pharmacology, biotech, clinical trials
Richmond Pharmacology, a contract research organisation (CRO) specialising in first-in-human and adaptive clinical trials, has appointed Dr Edward Jackson as …
Vesper Bio reports positive topline results for dementia candidate
November 7, 2025Research and Development Frontotemporal degeneration, Vesper Bio, clinical trials, dementia
Vesper Bio, a clinical-stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric disorders, has reported positive topline data from …
AAX Biotech and ToxoTech partner to develop next-gen biotherapeutics for neurological disorders
November 7, 2025Research and Development AAX Biotech, Biotherapeutics, ToxoTech, neurological disorders
AAX Biotech, a biotech company specialising in next-generation antibody therapeutics, has entered a strategic partnership with ToxoTech, a biopharma company …
Ardena appoints new Chief Quality Officer and Chief Information Officer
November 6, 2025Ardena, CDMO, CRO, Chief Information Officer, chief quality officer
Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO) and bioanalytical contract research organisation (CRO) focusing on precision medicines, …
Draig Therapeutics appoints Ivana Magovčević-Liebisch as President and CEO
November 5, 2025Draig Therapeutics, Neuropsychiatry, neuroscience
Draig Therapeutics, a Welsh clinical-stage company developing glutamate and GABA-based treatments for neuropsychiatry, has appointed Ivana Magovčević-Liebisch as President and …
Von Willebrand disease – increasing awareness and access to vital care
November 4, 2025Medical Communications, Research and Development European Medicines Association, Haematology, Takeda, Von Willebrand Disease, clinical trials, disease awareness
Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about Von Willebrand disease, its causes …
Rethinking oncology trial endpoints with generalised pairwise comparisons
November 4, 2025Research and Development EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology
For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …
VALANX Biotech appoints Klaus Orlinger as Chief Scientific Officer
November 4, 2025Antibody-Drug Conjugate, VALANX Biotech, drug development
VALANX Biotech, a company developing novel technology for site-specific protein conjugation in drug discovery, has appointed Klause Orlinger as Chief …
The Pharma Files: with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust
November 3, 2025Medical Communications, Research and Development Corporate, NHS, The Pharma Files, healthcare professionals, patient care, patients
Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …
Five Facts about men’s mental health
October 31, 2025Medical Communications Five Facts, mental health, men’s mental health
1 While only 15.4% of men are diagnosed with a common mental health condition (CMHC’s) in the UK (compared to …
Latest content
FibroFind appoints Lee Borthwick as CEO
